Clinical management of obese patients with cancer (Q38121736)

29 August 2017

Clinical management of obese patients with cancer (English)

1 reference

29 August 2017

0 references

2

1 reference

29 August 2017

1

Wenjing Tao

1 reference

PubMed ID

23856746

29 August 2017

language of work or name

English

0 references

publication date

16 July 2013

1 reference

Nature Reviews Clinical Oncology

29 August 2017

1 reference

29 August 2017

10

1 reference

29 August 2017

519-533

1 reference

29 August 2017

9

1 reference

A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.

29 August 2017

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Body mass index at diagnosis and survival among colon cancer patients enrolled in clinical trials of adjuvant chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Physical activity and obesity in endometrial cancer survivors: associations with pain, fatigue, and physical functioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

The role of the IGF system in cancer growth and metastasis: overview and recent insights

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Pathophysiology of sex hormone binding globulin (SHBG): relation to insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

The role of adiponectin in cancer: a review of current evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

The role of obesity in cancer survival and recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Measuring abdominal obesity: effects of height on distribution of cardiometabolic risk factors risk using waist circumference and waist-to-height ratio.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

More on body fat cutoff points

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Abdominal Obesity and the Risk of All-Cause, Cardiovascular, and Cancer Mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Bariatric surgery to treat obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Using the Edmonton obesity staging system to predict mortality in a population-representative cohort of people with overweight and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Metabolically healthy obesity: different prevalences using different criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Metabolically healthy obesity and risk of all-cause and cardiovascular disease mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

The association of obesity and cervical cancer screening: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Obesity and mammography: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Body mass index and colon cancer screening: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Obese women's barriers to mammography and pap smear: the possible role of personality

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

The effects of body mass index on changes in prostate-specific antigen levels and prostate volume over 15 years of follow-up: implications for prostate cancer detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Obesity and prostate cancer detection: insights from three national surveys

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Influence of obesity on tumour volume in patients with prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Obesity-PSA relationship: a new formula

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Relationship between prostate-specific antigen, age, and body mass index in a prostate cancer screening population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

The clinical significance in healthy men of the association between obesity related plasma hemodilution and tumor marker concentration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Influence of obesity on the serum carcinoembryonic antigen value in patients with colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Is rectal MRI beneficial for determining the location of rectal cancer with respect to the peritoneal reflection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Impact of MRI in the management and staging of cancer of the uterine cervix.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Impact of obesity on medical imaging and image-guided intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Features of cancer management in obese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

The obese emergency patient: imaging challenges and solutions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Increased radiation dose to overweight and obese patients from radiographic examinations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Appropriate chemotherapy dosing for obese adult patients with cancer: American Society of Clinical Oncology clinical practice guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Effects of obesity on pharmacokinetics implications for drug therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Evaluation of chemotherapy-induced severe myelosuppression incidence in obese patients with capped dosing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Breast cancer adjuvant chemotherapy dosing in obese patients: dissemination of information from clinical trials to clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Comparison of ideal body weight equations and published height-weight tables with body mass index tables for healthy adults in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Effect of obesity on the leukocyte nadir in women treated with adjuvant cyclophosphamide, methotrexate, and fluorouracil dosed according to body surface area

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Influence of body mass index on outcome in advanced colorectal cancer patients receiving chemotherapy with or without targeted therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Body mass index and outcomes in patients receiving chemotherapy for intermediate-grade B-cell non-Hodgkin lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Implications of obesity for drug therapy: limitations and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Effect of body mass index on recurrences in tamoxifen and anastrozole treated women: an exploratory analysis from the ATAC trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Endocrine therapy in obese patients with primary breast cancer: another piece of evidence in an unfinished puzzle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Obesity and hormone therapy in breast cancer: an unfinished puzzle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Androgen deprivation therapy for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Obesity and sex steroids during gonadotropin-releasing hormone agonist treatment for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Testosterone levels in patients with metastatic prostate cancer treated with luteinizing hormone-releasing hormone therapy: prognostic significance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Obesity is associated with castration-resistant disease and metastasis in men treated with androgen deprivation therapy after radical prostatectomy: results from the SEARCH database

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Obesity and prostate cancer: epidemiology and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Body mass index is not a prognostic marker for prostate-specific antigen failure and survival in Dutch men treated with brachytherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

In pursuit of individualised margins for prostate cancer patients undergoing image-guided radiotherapy: the effect of body mass index on intrafraction prostate motion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Proton beam therapy and concurrent chemotherapy for esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Effect of body mass index on shifts in ultrasound-based image-guided intensity-modulated radiation therapy for abdominal malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Set-up errors in patients undergoing image guided radiation treatment. Relationship to body mass index and weight loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Obesity increases the risk of chest wall pain from thoracic stereotactic body radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Adjuvant treatment and survival in obese women with endometrial cancer: an international collaborative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Permanent prostate brachytherapy-induced morbidity in patients with grade II and III obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

The impact of obesity on surgical outcomes: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Obesity and perioperative outcomes in endometrial cancer surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Body mass index and outcomes from pancreatic resection: a review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

The impact of preoperative body mass index on respiratory complications after pneumonectomy for non-small-cell lung cancer. Results from a series of 154 consecutive standard pneumonectomies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Body mass index and breast cancer treatment-related lymphedema

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Is laparoscopic colorectal cancer surgery in obese patients associated with an increased risk? Short-term results from a single center study of 425 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

A high body mass index in esophageal cancer patients does not influence postoperative outcome or long-term survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Obesity is associated with worse oncological outcomes in patients treated with radical cystectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Obesity adversely impacts disease specific outcomes in patients with upper tract urothelial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Impact of obesity on operative morbidity and clinical outcome in primary epithelial ovarian cancer after optimal primary tumor debulking.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Laparoscopic and laparotomic approaches for endometrial cancer treatment: a comprehensive review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Surgical and oncological outcome of total laparoscopic radical hysterectomy in obese women with early-stage cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Effect of obesity on technical feasibility and postoperative outcomes of laparoscopy-assisted distal gastrectomy--comparison with open distal gastrectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

The benefit of laparoscopic partial nephrectomy in high body mass index patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Comparison of open and laparoscopic nephrectomy in obese and nonobese patients: outcomes stratified by body mass index

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

The impact of obesity on perioperative outcomes after laparoscopic colorectal resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Surgical outcome of robotic surgery in morbidly obese patient with endometrial cancer compared to laparotomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

A cohort study evaluating robotic versus laparotomy surgical outcomes of obese women with endometrial carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Influence of obesity on the incidence and treatment of genitourinary malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Obesity does not preclude safe and effective myeloablative hematopoietic cell transplantation (HCT) for acute myelogenous leukemia (AML) in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Effect of body mass index on mortality of patients with lymphoma undergoing autologous hematopoietic cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Effect of obesity on outcomes after autologous hematopoietic stem cell transplantation for multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Allogeneic transplant outcomes are not affected by body mass index (BMI) in patients with haematological malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

The relationship between body mass index and outcomes in leukemic patients undergoing allogeneic hematopoietic stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Obesity in cancer survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Lower lung cancer mortality in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Body-mass index and cancer mortality in the Asia-Pacific Cohort Studies Collaboration: pooled analyses of 424,519 participants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Prediagnosis body mass index, physical activity, and mortality in endometrial cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Effect of obesity on survival of women with epithelial ovarian cancer: a systematic review and meta-analysis of observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Increased body mass index is associated with improved survival in United States veterans with diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Body mass index does not influence post-treatment survival in early stage endometrial cancer: results from the MRC ASTEC trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Body mass index and survival in patients with renal cell carcinoma: a clinical-based cohort and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

The risk of upstaged disease increases with body mass index in low-risk prostate cancer patients eligible for active surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Body mass index, tumor characteristics, and prognosis following diagnosis of early-stage breast cancer in a mammographically screened population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Associations between lifestyle factors and quality of life among older long-term breast, prostate, and colorectal cancer survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Predictors of postoperative quality of life after esophagectomy for cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Exercise interventions for cancer survivors: a meta-analysis of quality of life outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Gynecological cancer survivors' health behaviors and their associations with quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Associations among physical activity, body mass index, and health-related quality of life by race/ethnicity in a diverse sample of breast cancer survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Associations among exercise, body weight, and quality of life in a population-based sample of endometrial cancer survivors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Reach out to enhance wellness home-based diet-exercise intervention promotes reproducible and sustainable long-term improvements in health behaviors, body weight, and physical functioning in older, overweight/obese cancer survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Impact of body mass index on compliance and persistence to adjuvant breast cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Comorbidity and age as predictors of risk for early mortality of male and female colon carcinoma patients: a population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Drug interactions in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Understanding the mechanisms and treatment options in cancer cachexia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Sarcopenia in an Overweight or Obese Patient Is an Adverse Prognostic Factor in Pancreatic Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Nutritional intervention and quality of life in adult oncology patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Updated evidence in support of diet and exercise interventions in cancer survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Body mass index before and after breast cancer diagnosis: associations with all-cause, breast cancer, and cardiovascular disease mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Impact of body mass index and weight change after treatment on cancer recurrence and survival in patients with stage III colon cancer: findings from Cancer and Leukemia Group B 89803.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Physical activity and survival after breast cancer diagnosis: meta-analysis of published studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Physical activity after diagnosis and risk of prostate cancer progression: data from the cancer of the prostate strategic urologic research endeavor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Dietary fat reduction and breast cancer outcome: interim efficacy results from the Women's Intervention Nutrition Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Influence of a diet very high in vegetables, fruit, and fiber and low in fat on prognosis following treatment for breast cancer: the Women's Healthy Eating and Living (WHEL) randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

The role of diet and physical activity in breast, colorectal, and prostate cancer survivorship: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Sarcopenic obesity in the elderly and strategies for weight management

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Competing causes of death from a randomized trial of extended adjuvant endocrine therapy for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

mTOR signaling in growth control and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Next-generation mTOR inhibitors in clinical oncology: how pathway complexity informs therapeutic strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Metformin and cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Metformin and the risk of cancer: time-related biases in observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Cancer risk in diabetic patients treated with metformin: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Cancer outcomes and all-cause mortality in adults allocated to metformin: systematic review and collaborative meta-analysis of randomised clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Metformin in cancer: translational challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

A systematic review of waist-to-height ratio as a screening tool for the prediction of cardiovascular disease and diabetes: 0·5 could be a suitable global boundary value

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Adjusted body weight, con: why adjust body weight in energy-expenditure calculations?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Body surface area in normal-weight, overweight, and obese adults. A comparison study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Physical activity and obesity in Canadian cancer survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Comorbidity and Survival Disparities Among Black and White Patients With Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Obesity and cancer: Pathophysiological and biological mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Body mass index and percent body fat: a meta analysis among different ethnic groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Relationship between body mass index and prostate cancer screening in the United States

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Imaging obese patients: problems and solutions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Undertreatment of obese women receiving breast cancer chemotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Effects of tumor type, degree of obesity, and chemotherapy regimen on chemotherapy dose intensity in obese cancer patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Chemotherapy dose reductions in obese patients with colorectal cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Impact of Body Mass Index on the Efficacy of Endocrine Therapy in Premenopausal Patients With Breast Cancer: An Analysis of the Prospective ABCSG-12 Trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Effect of obesity on prostate-specific antigen recurrence after radiation therapy for localized prostate cancer as measured by the 2006 Radiation Therapy Oncology Group-American Society for Therapeutic Radiation and Oncology (RTOG-ASTRO) Phoenix con

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Prostate brachytherapy in obese patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Potential for higher treatment failure in obese patients: correlation of elevated body mass index and increased daily prostate deviations from the radiation beam isocenters in an analysis of 1,465 computed tomographic images

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Effect of body mass index on magnitude of setup errors in patients treated with adjuvant radiotherapy for endometrial cancer with daily image guidance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Inter- and intrafractional localisation errors in cone-beam CT guided stereotactic radiation therapy of tumours in the liver and lung

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Prognostic impact of abdominal adiposity, waist circumference and body mass index in patients with intermediate-risk prostate cancer treated with radiotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Body mass index and major cancer surgery outcomes: lack of association or need for alternative measurements of obesity?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Impact of body mass index on perioperative outcomes in patients undergoing major intra-abdominal cancer surgery

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Does obesity affect outcomes in patients undergoing esophagectomy for cancer? A meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Body mass index and survival in esophageal adenocarcinoma treated with chemoradiotherapy followed by esophagectomy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Laparoscopic colorectal cancer surgery in obese patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Total laparoscopic hysterectomy for early stage endometrial cancer in obese and morbidly obese women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Long-term follow-up after laparoscopic management of endometrial cancer in the obese: a fifteen-year cohort study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Obesity and autologous stem cell transplantation in acute myeloid leukemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Impact of obesity on allogeneic stem cell transplant patients: a matched case-controlled study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Body mass index and survival in patients with epithelial ovarian cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Impact of body mass index on survival after colorectal cancer diagnosis: the Cancer Prevention Study-II Nutrition Cohort

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Cachexia but not obesity worsens the postoperative outcome after pancreatoduodenectomy in pancreatic cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Quality of life in endometrial cancer survivors: what does obesity have to do with it?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Excess baggage: sarcopenia, obesity, and cancer outcomes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Body composition and outcome in patients undergoing resection of colorectal liver metastases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Changes in weight, body composition, and factors influencing energy balance among premenopausal breast cancer patients receiving adjuvant chemotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Clinical Pharmacy: Case Studies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.120

Shields M., Carroll M.D., Ogden C.L. adult obesity prevalence in Canada and the United States. NCHS data brief no. 56, Hyattsville, MD: National Center for Health Statistics, 2011.

31 March 2020

1 reference

12 December 2020

Obesity: preventing and managing the global epidemic. Report of a WHO consultation

1 reference

12 December 2020

Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages

1 reference

12 December 2020

Obesity and Cancer Screening according to Race and Gender

1 reference

12 December 2020

Techniques for the measurement of visceral fat: a practical guide

1 reference

12 December 2020

10.1038/NRCLINONC.2013.120

Identifiers

DOI

1 reference

29 August 2017

1 reference

PubMed ID

23856746